These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 14612146)

  • 1. Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine.
    Kahlig KM; Galli A
    Eur J Pharmacol; 2003 Oct; 479(1-3):153-8. PubMed ID: 14612146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter.
    Pifl C; Drobny H; Reither H; Hornykiewicz O; Singer EA
    Mol Pharmacol; 1995 Feb; 47(2):368-73. PubMed ID: 7870046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphetamine regulation of dopamine transport. Combined measurements of transporter currents and transporter imaging support the endocytosis of an active carrier.
    Kahlig KM; Javitch JA; Galli A
    J Biol Chem; 2004 Mar; 279(10):8966-75. PubMed ID: 14699142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine transporter-dependent induction of C-Fos in HEK cells.
    Yatin SM; Miller GM; Norton C; Madras BK
    Synapse; 2002 Jul; 45(1):52-65. PubMed ID: 12112414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism.
    Saunders C; Ferrer JV; Shi L; Chen J; Merrill G; Lamb ME; Leeb-Lundberg LM; Carvelli L; Javitch JA; Galli A
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6850-5. PubMed ID: 10823899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution.
    Garcia BG; Wei Y; Moron JA; Lin RZ; Javitch JA; Galli A
    Mol Pharmacol; 2005 Jul; 68(1):102-9. PubMed ID: 15795321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of cocaine and dopamine transporter inhibitors on behavior and neurochemistry in monkeys.
    Ginsburg BC; Kimmel HL; Carroll FI; Goodman MM; Howell LL
    Pharmacol Biochem Behav; 2005 Mar; 80(3):481-91. PubMed ID: 15740791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dopamine transporter expression level differentially affects responses to cocaine and amphetamine.
    Cagniard B; Sotnikova TD; Gainetdinov RR; Zhuang X
    J Neurogenet; 2014; 28(1-2):112-21. PubMed ID: 24673634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter.
    Giros B; Jaber M; Jones SR; Wightman RM; Caron MG
    Nature; 1996 Feb; 379(6566):606-12. PubMed ID: 8628395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dopamine transporter: a vigilant border control for psychostimulant action.
    Williams JM; Galli A
    Handb Exp Pharmacol; 2006; (175):215-32. PubMed ID: 16722238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluctuation of the dopamine uptake inhibition potency of cocaine, but not amphetamine, at mammalian cells expressing the dopamine transporter.
    Ukairo OT; Ramanujapuram S; Surratt CK
    Brain Res; 2007 Feb; 1131(1):68-76. PubMed ID: 17169338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid regulation of the dopamine transporter: role in stimulant addiction?
    Zahniser NR; Sorkin A
    Neuropharmacology; 2004; 47 Suppl 1():80-91. PubMed ID: 15464127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging.
    Lindsey KP; Wilcox KM; Votaw JR; Goodman MM; Plisson C; Carroll FI; Rice KC; Howell LL
    J Pharmacol Exp Ther; 2004 Jun; 309(3):959-69. PubMed ID: 14982963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine and norepinephrine transporter-dependent c-Fos production in vitro: relevance to neuroadaptation.
    Yatin SM; Miller GM; Madras BK
    J Neurosci Methods; 2005 Apr; 143(1):69-78. PubMed ID: 15763138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic regulation of the dopamine transporter.
    Mortensen OV; Amara SG
    Eur J Pharmacol; 2003 Oct; 479(1-3):159-70. PubMed ID: 14612147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cocaine and amphetamine elicit differential effects in rats with a unilateral injection of dopamine transporter antisense oligodeoxynucleotides.
    Silvia CP; Jaber M; King GR; Ellinwood EH; Caron MG
    Neuroscience; 1997 Feb; 76(3):737-47. PubMed ID: 9135047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual differences in cocaine- and amphetamine-induced activation of male Sprague-Dawley rats: contribution of the dopamine transporter.
    Briegleb SK; Gulley JM; Hoover BR; Zahniser NR
    Neuropsychopharmacology; 2004 Dec; 29(12):2168-79. PubMed ID: 15292903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychostimulants and monoamine transporters: upsetting the balance.
    Elliott JM; Beveridge TJ
    Curr Opin Pharmacol; 2005 Feb; 5(1):94-100. PubMed ID: 15661632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A triple mutation in the second transmembrane domain of mouse dopamine transporter markedly decreases sensitivity to cocaine and methylphenidate.
    Chen R; Han DD; Gu HH
    J Neurochem; 2005 Jul; 94(2):352-9. PubMed ID: 15998286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cocaine induction of dopamine transporter trafficking to the plasma membrane.
    Little KY; Elmer LW; Zhong H; Scheys JO; Zhang L
    Mol Pharmacol; 2002 Feb; 61(2):436-45. PubMed ID: 11809869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.